• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
APX

APPEN LIMITED - News & Media

4.18% ! $1.25
Market Cap $320.8M  !
Technology Information Technology Services
Add to My Watchlist

Appen Limited is engaged in the development of human-annotated datasets for machine... Appen Limited is engaged in the development of human-annotated datasets for machine learning and artificial intelligence. The Company is organized into two operating segments based on differences in products and services provided: Content Relevance and Language Resources. Content Relevance provides annotated data used in search technology (embedded in Web, e-commerce and social engagement) for improving relevance and accuracy of search engines, social media applications and e-commerce. Language Resources provides annotated speech, natural language and image data used in speech recognizers, machine translation, speech synthesizers and other machine-learning technologies resulting in engaging and fluent devices including Internet-connected devices, in-car automotive systems and speech-enabled consumer electronics.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Appen disappoints despite surging China results

Appen (ASX:APX) was down around -1.7% in lunchtime trade, after dropping its H1 FY25 results; a bit of the mixed bag with a China win.

28 Aug 2025 12:40 (AEST)

Appen appoints Ryan Kolln as CEO and Managing Director

Appen (ASX:APX) has announced the immediate appointment of Ryan Kolln as its new CEO and Managing Director, succeeding Armughan Ahmad, who has stepped down.

05 Feb 2024 13:51 (AEDT)

Appen shares plunge as Google ends services contract

Tech stock Appen (ASX:APX) has plummeted 40 per cent today following the termination of its global inbound services contract with Google.

22 Jan 2024 14:17 (AEDT)

Appen (ASX:APX) shares slide on release of 1H23 results

Appen (ASX:APX) has reported its half-year results for the 2023 calendar year, where ongoing external operating and macroeconomic conditions have led to a decline in revenue.

28 Aug 2023 12:54 (AEST)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
$1.25 		Change
0.050(4.18%) 		Mkt cap ! $320.8M
Open High Low Volume
$1.20 $1.25 $1.19 3.504M

Buyers (Bids)

Vol. Price($)
2800 $1.23
 

Sellers (Offers)

Price($) Vol.
$1.24 12719
Last trade - 16.10pm 03/08/2026 (20 minute delay) ?
APX (ASX) Chart

Top Stories

Klevo Rewards advances stablecoin strategy with credit licence acquisition

Klevo Rewards CEO Alexander Gold talks to HotCopper about officially completing the acquisition of an Australian credit licence.
Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor Economist Stephen Koukoulas breaks down Michele Bullock's RBA legacy so far and what her final years as Governor could mean for Aussies.
Diablo expands critical minerals footprint at Star Range Welcome to HotCopper’s latest Watchlist, where this week we’ve been joined by Diablo Resources (ASX:DBO) CEO Lyle Thorne to discuss recent exploration that’s @expanded the scale” at Star Range in Beaver County, Utah.Listen to t...
Prairie Lithium advances towards first production as commercial DLE unit arrives Prairie Lithium (ASX:PL9) has reached a major milestone in its path to first production, with North America’s largest commercial Direct Lithium Extraction (DLE) unit now delivered to site in Saskatchewan. The arrival marks the start of installation as the ASX-listed company moves ...
AFT Pharmaceutical's multi-billion R&D opportunity Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.